<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02646462</url>
  </required_header>
  <id_info>
    <org_study_id>24</org_study_id>
    <nct_id>NCT02646462</nct_id>
  </id_info>
  <brief_title>Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic Cancer</brief_title>
  <official_title>Systematic Lymph Node Sampling and Analysis in Patients Undergoing Radical Resection for Pancreatic Cancer. A National Danish Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Michael Bau Mortensen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective investigation of the ratio between malignant and total number of lymph nodes in
      predefined lymph node stations in patients resected for pancreatic adenocarcinoma. A national
      Danish project.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lymph nodes will be sampled from the following stations in patients with adenocarcinomas of
      the pancreas Group 6: Infrapyloric lymph nodes (IP) Group 8: Lymph nodes around the common
      hepatic artery (CHA) Group 12: Lymph nodes of the hepatoduodenal ligament (HDL) Group 13:
      Posterior pancreaticoduodenal lymph nodes Group 14: Lymph nodes around the superior
      mesenteric artery (SMA) Group 17: Anterior pancreaticoduodenal lymph nodes
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ratio of malignant/total number of lymph nodes</measure>
    <time_frame>12 months</time_frame>
    <description>Ratio between malignant and total number of lymph nodes in predefined lymph node stations</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of N1 patients</measure>
    <time_frame>12 months</time_frame>
    <description>Number of patients with malignant lymph nodes in predefined lymph node stations</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Pancreatic Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Bioptic verified pancreatic adenocarcinoma or periampullary adenocarcinoma (within 20mm of
        the papilla) referred for pancreas resection
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Bioptic verified pancreatic adenocarcinoma or periampullary adenocarcinoma (within 20mm of
        the papilla)

        Exclusion Criteria:

        Patients with non-adenocarcinoma tumors of the pancreas or periampullary region
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael B Mortensen, MD, PhD,</last_name>
    <phone>45 6541 1857</phone>
    <email>michael.bau.mortensen@rsyd.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense C</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael B Mortensen, MD, PhD</last_name>
      <phone>45 6541 1857</phone>
      <email>michael.bau.mortensen@rsyd.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 5, 2015</study_first_submitted>
  <study_first_submitted_qc>January 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 5, 2016</study_first_posted>
  <last_update_submitted>January 6, 2016</last_update_submitted>
  <last_update_submitted_qc>January 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Michael Bau Mortensen</investigator_full_name>
    <investigator_title>professor, MD, PhD, DMSci</investigator_title>
  </responsible_party>
  <keyword>pancreas adenocarcinoma, lymph node metastases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

